Clinical practice guidelines for the treatment of squamous cell carcinoma of the head and neck: an assessment based on the AGREE II, AGREE-REX tools and the RIGHT checklist
2024

Assessing Clinical Practice Guidelines for Head and Neck Squamous Cell Carcinoma

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Zhang Yingzhen, Liu Junjie, Liu Shuyu, Zhang Ying, Su Xingzhou, Huang Shaohui, Duan Weiyi

Primary Institution: School and Hospital of Stomatology, China Medical University

Hypothesis

The study aims to assess and compare the quality of clinical practice guidelines for head and neck squamous cell carcinoma using specific evaluation tools.

Conclusion

The authors recommend the American Society of Clinical Oncology guidelines for HNSCC and suggest improvements for future guideline development.

Supporting Evidence

  • Four guidelines scored over 60% in five or more AGREE II quality domains.
  • Two guidelines scored over 60% in all AGREE-REX quality domains.
  • Two guidelines were considered 'recommendable' based on the RIGHT checklist.

Takeaway

This study looked at different guidelines for treating a type of throat cancer and found some are better than others, suggesting which ones doctors should use.

Methodology

The study involved a systematic literature search to identify guidelines, which were then evaluated using AGREE II, AGREE-REX, and RIGHT tools.

Potential Biases

Potential conflicts of interest among guideline developers may affect the impartiality of the recommendations.

Limitations

The study included a small number of guidelines and may have been affected by language barriers and potential biases in guideline selection.

Digital Object Identifier (DOI)

10.3389/fonc.2024.1442657

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication